Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Compared to the amniotic membrane, Wharton’s jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration

Fig. 4

Antiplatelet adhesion properties of WJ-MSCs and AM-MSCs. Morphologies of HUVECs (a), WJ-MSCs (c), and AM-MSCs (e). Representative SEM images of platelets adhered, HUVECs (b), WJ-MSCs (d), AM-MSCs (f), and non-cell-seeded control group (h). White arrow indicates the aggregated platelets. (g) Quantitative evaluation of nonadherent platelets in plasma. Mean ± SD. * P > 0.05, no statistical significance between groups; ** P < 0.05, significant difference between groups. AM-MSCs amniotic membrane mesenchymal stem cells, HUVECs human umbilical vein endothelial cells, WJ-MSCs Wharton’s jelly mesenchymal stem cells

Back to article page